ICL Group (ICL) is back in focus after announcing a new specialty fertilizer facility in Maharashtra, India, aimed at supporting local production as geopolitical tensions disrupt key global shipping routes.

Despite the India expansion headlines, ICL's recent share price moves have been subdued, with a 7 day share price return of a 4.28% decline and a year to date share price return of an 11.05% decline, while the 5 year total shareholder return sits at 5.97%.

If this fertilizer expansion has you thinking more broadly about materials exposure, it could be worth scanning 8 top copper producer stocks

With ICL shares down year to date despite the India expansion plans and trading below the average analyst price target, the key question is whether this is a mispriced entry point or if markets already anticipate the growth.

Most Popular Narrative: 23.6% Undervalued

ICL Group's most followed narrative pegs fair value at $6.74 per share compared with a last close of $5.15. This frames the India fertilizer expansion against an already discounted share price.

The company's innovation and investment in new product pipelines, particularly in areas like battery materials and specialty fertilizers, indicate potential for future revenue growth and expanded market opportunities, which could positively impact net margins.

The narrative raises the question of what supports that higher fair value. It leans heavily on steady revenue gains, stronger margins, and a future earnings multiple that is described as below the broader chemicals group.

Result: Fair Value of $6.74 (UNDERVALUED)

However, there are still clear watchpoints, including geopolitics that could pressure shipping costs and margins, as well as high phosphate exposure if pricing or demand weakens.

Another View: Multiples Paint a Tougher Picture

That 23.6% undervaluation story sits awkwardly next to how the market is pricing ICL today. On a P/E of 29.4x, the stock trades above both its peer group at 16.6x and the broader US Chemicals industry at 26.4x, which implies investors are already paying up for future improvement.

When a company screens as expensive on current earnings while also being framed as undervalued on fair value estimates, it puts the onus back on you. Is the earnings recovery implied in those narratives realistic enough to justify paying this kind of premium multiple?

Next Steps

If the mixed signals here leave you unsure, do not wait for the market to tell you the answer. Instead, review the company's 4 important warning signs

Looking for more investment ideas?

If ICL has caught your attention, do not stop here. Use these focused stock ideas to quickly widen your watchlist and spot opportunities others might overlook.

• Target potential mispricings by scanning companies that look cheaper on quality and fundamentals with the help of 58 high quality undervalued stocks
• Strengthen your income stream by reviewing companies with robust payout profiles using the 13 dividend fortresses
• Prioritise resilience by checking companies with sturdier balance sheets and solid fundamentals through the solid balance sheet and fundamentals stocks screener (39 results)

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.